Status:
TERMINATED
Macular Pigment Optical Density in Healthy Subjects
Lead Sponsor:
Medical University of Vienna
Conditions:
Age Related Macular Degeneration
Eligibility:
All Genders
18-90 years
Brief Summary
The macular pigment (MP) in humans consists of the yellow, blue-absorbing carotenoids lutein and zeaxanthin, which are contained in vegetables and fruits. The highest concentrations of lutein and zeax...
Eligibility Criteria
Inclusion
- Healthy subjects without any signs of AMD
- Age between 18 and 90 years, (20 subjects aged between 18 and 40, 20 subjects aged between 41 and 50, 20 subjects aged between 51 and 60, 20 subjects aged between 61 and 70, 20 subjects aged between 71 and 80, 20 subjects aged between 81 and 90)
- Clear non-lenticular ocular media
- Visual acuity \> 0.6
Exclusion
- Any sign of AMD, or another retinal or optic nerve head disease
- Ocular surgery within the last 6 months
- Treatment with photosensitizing drugs
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00993330
Start Date
May 1 2009
End Date
December 1 2010
Last Update
November 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Pharmacology, Medical University of Vienna
Vienna, Austria, 1090